GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | 10/30/2026 8:12:40 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2026 ending: 9/30/2026 | Rev: $83,699,000 +13.9% | Assets $825,704,000 | EPS $0.23 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 10/30/2026 8:04:19 AM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $83,699,000 +13.9% | Assets $825,704,000 | EPS $0.23 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/6/2026 8:26:27 AM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $83,220,000 +18.9% | Assets $792,262,000 | EPS $0.28 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/6/2026 8:06:35 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $83,220,000 +18.9% | Assets $792,262,000 | EPS $0.28 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/7/2026 8:34:23 AM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $77,705,000 +24.4% | Assets $723,997,000 | EPS $0.25 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/7/2026 8:24:59 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $77,705,000 +24.4% | Assets $723,997,000 | EPS $0.25 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 4/21/2026 4:41:22 PM | View | Proxy | SEC | Y 2025 | ||||||
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/26/2026 6:16:43 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $283,055,000 +20.4% | Assets $751,587,000 | EPS $2.07 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/26/2026 6:10:11 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $77,114,000 +28.8% | Assets $751,587,000 | EPS $1.53 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/4/2025 8:01:46 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $73,468,000 +8.4% | Assets $527,528,000 | EPS $0.23 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/4/2025 6:12:40 AM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $73,468,000 +8.4% | Assets $527,528,000 | EPS $0.23 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 7/31/2025 6:21:32 AM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $70,008,000 +22.4% | Assets $502,562,000 | EPS $0.16 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 7/31/2025 6:12:11 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $70,008,000 +22.4% | Assets $502,562,000 | EPS $0.16 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/12/2025 6:16:40 AM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $62,465,000 +24.2% | Assets $504,850,000 | EPS $0.16 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/12/2025 6:03:54 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $62,465,000 +24.2% | Assets $504,850,000 | EPS $0.16 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 4/17/2025 4:04:43 PM | View | Proxy | SEC | Y 2024 | ||||||
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/27/2025 6:26:45 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $235,133,000 +34.0% | Assets $550,645,000 | EPS $0.04 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/27/2025 6:08:57 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $59,867,000 +32.8% | Assets $550,645,000 | EPS $0.01 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/7/2024 6:30:48 AM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $67,771,000 +24.3% | Assets $549,361,000 | EPS $0.10 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/7/2024 6:14:33 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $67,771,000 +24.3% | Assets $549,361,000 | EPS $0.10 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/1/2024 6:19:47 AM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $57,192,000 +37.8% | Assets $523,529,000 | EPS $0.01 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/1/2024 6:06:33 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $57,192,000 +37.8% | Assets $523,529,000 | EPS $0.01 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/3/2024 4:10:00 PM | View | Proxy | SEC | Y 2023 | ||||||
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/2/2024 6:17:03 AM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $50,303,000 +46.2% | Assets $516,634,000 | EPS -$0.07 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/2/2024 6:07:57 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $50,303,000 +46.2% | Assets $516,634,000 | EPS -$0.07 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 4/29/2024 4:28:52 PM | Small | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Rev: $175,513,000 +31.0% | Assets $548,062,000 | EPS -$0.54 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/15/2024 6:29:48 AM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $175,513,000 +31.0% | Assets $548,062,000 | EPS -$0.54 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/15/2024 6:13:09 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $45,095,000 +58.6% | Assets $548,062,000 | EPS -$0.19 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 1/5/2024 6:03:54 AM | View | Financials | Earnings (Prelim) | SEC | Y 2023 | Export Earnings Model | ||||
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/2/2023 6:16:01 AM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $54,515,000 -2.3% | Assets $555,013,000 | EPS -$0.09 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/2/2023 6:08:04 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $54,515,000 -2.3% | Assets $555,013,000 | EPS -$0.09 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/3/2023 6:15:57 AM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $41,494,000 +47.2% | Assets $548,900,000 | EPS -$0.08 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/3/2023 6:14:03 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $41,494,000 +47.2% | Assets $548,900,000 | EPS -$0.08 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/4/2023 6:21:19 AM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $34,409,000 +59.1% | Assets $451,761,000 | EPS -$0.18 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/4/2023 6:09:27 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $34,409,000 +59.1% | Assets $451,761,000 | EPS -$0.18 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 4/18/2023 4:27:19 PM | View | Proxy | SEC | Y 2022 | ||||||
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/28/2023 6:30:02 AM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $134,030,000 +193.9% | Assets $470,860,000 | EPS -$0.76 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/28/2023 6:10:40 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $28,435,000 +21.5% | Assets $470,860,000 | EPS -$0.18 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 1/9/2023 4:12:22 PM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/3/2022 6:26:24 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $55,779,000 +280.3% | Assets $488,293,000 | EPS -$0.06 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/3/2022 6:10:04 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $55,779,000 +280.3% | Assets $488,293,000 | EPS -$0.06 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/4/2022 6:38:35 AM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $28,191,000 +325.8% | Assets $482,148,000 | EPS -$0.25 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/4/2022 6:10:38 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $28,191,000 +325.8% | Assets $482,148,000 | EPS -$0.25 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/10/2022 6:31:27 AM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $21,625,000 +2,266.0% | Assets $506,902,000 | EPS -$0.27 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/10/2022 6:10:45 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $21,625,000 +2,266.0% | Assets $506,902,000 | EPS -$0.27 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 4/18/2022 7:36:12 AM | View | Proxy | SEC | Y 2021 | ||||||
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/28/2022 6:25:09 AM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $45,605,000 -9.0% | Assets $543,367,000 | EPS -$1.40 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/28/2022 6:14:44 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $23,404,000 -53.2% | Assets $543,367,000 | EPS -$0.25 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/3/2021 4:25:18 PM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $14,667,000 +50,475.9% | Assets $360,066,000 | EPS -$0.39 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/3/2021 6:02:53 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $14,667,000 +50,475.9% | Assets $360,066,000 | EPS -$0.39 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/5/2021 4:27:56 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $6,620,000 +22,727.6% | Assets $386,268,000 | EPS -$0.37 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/5/2021 4:26:42 PM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $6,620,000 +22,727.6% | Assets $386,268,000 | EPS -$0.37 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/10/2021 4:11:13 PM | View | Proxy | SEC | Y 2020 | ||||||
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/6/2021 4:26:03 PM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $914,000 +2,946.7% | Assets $417,078,000 | EPS -$0.40 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/6/2021 4:10:45 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $914,000 +2,946.7% | Assets $417,078,000 | EPS -$0.40 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 4/30/2021 4:25:32 PM | Small | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Rev: $50,118,000 +15,660.4% | Assets $463,661,000 | EPS -$0.87 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/24/2021 4:23:12 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $50,118,000 +15,660.4% | Assets $463,661,000 | EPS -$0.87 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 2/24/2021 4:19:34 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $50,030,000 +172,417.2% | Assets $463,661,000 | EPS -$0.06 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/10/2020 4:06:39 PM | View | Financials | Earnings | WIRE | 3Q 2020 | Rev $29,000 -87.4% | EPS -$0.34 | Export Earnings Model | ||
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/11/2020 4:07:16 PM | View | Financials | Earnings | WIRE | 2Q 2020 | Rev $29,000 0.0% | EPS -$0.24 | Export Earnings Model | ||
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/14/2020 4:16:28 PM | View | Financials | Earnings | WIRE | 1Q 2020 | Rev $30,000 0.0% | EPS -$0.23 | Export Earnings Model | ||
| Aurinia Pharmaceuticals Inc. (AUPH) | 3/5/2020 4:08:32 PM | View | Financials | Earnings | WIRE | Y 2019 | Rev $29,000 | Assets $324,301,000 | EPS -$0.79 | Export Earnings Model | |
| Aurinia Pharmaceuticals Inc. (AUPH) | 11/14/2019 4:05:53 PM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $230,000 | Export Earnings Model | |||
| Aurinia Pharmaceuticals Inc. (AUPH) | 8/6/2019 4:05:12 PM | View | Financials | Earnings | WIRE | 2Q 2019 | Rev $29,000 | Export Earnings Model | |||
| Aurinia Pharmaceuticals Inc. (AUPH) | 5/14/2019 4:06:09 PM | View | Financials | Earnings | WIRE | 1Q 2019 | Rev $30,000 | EPS -$0.16 | Export Earnings Model |